Grand Jean Capital Management Inc. trimmed its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 86,720 shares of the medical research company’s stock after selling 4,608 shares during the period. Thermo Fisher Scientific comprises about 7.4% of Grand Jean Capital Management Inc.’s portfolio, making the stock its 3rd largest position. Grand Jean Capital Management Inc.’s holdings in Thermo Fisher Scientific were worth $21,167,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. First Trust Advisors LP grew its position in shares of Thermo Fisher Scientific by 92.5% in the 3rd quarter. First Trust Advisors LP now owns 303,090 shares of the medical research company’s stock valued at $73,978,000 after acquiring an additional 145,619 shares during the period. Swiss National Bank grew its position in shares of Thermo Fisher Scientific by 3.2% in the 2nd quarter. Swiss National Bank now owns 1,328,332 shares of the medical research company’s stock valued at $275,151,000 after acquiring an additional 41,800 shares during the period. Massmutual Trust Co. FSB ADV grew its position in shares of Thermo Fisher Scientific by 6,260.5% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 13,039 shares of the medical research company’s stock valued at $2,701,000 after acquiring an additional 12,834 shares during the period. Oakworth Capital Inc. grew its position in shares of Thermo Fisher Scientific by 30.0% in the 3rd quarter. Oakworth Capital Inc. now owns 1,476 shares of the medical research company’s stock valued at $360,000 after acquiring an additional 341 shares during the period. Finally, Rockefeller Capital Management L.P. grew its position in shares of Thermo Fisher Scientific by 1.9% in the 2nd quarter. Rockefeller Capital Management L.P. now owns 19,770 shares of the medical research company’s stock valued at $4,095,000 after acquiring an additional 375 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

In other news, CEO Marc N. Casper sold 125,520 shares of the firm’s stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $247.50, for a total transaction of $31,066,200.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.49% of the company’s stock.

NYSE TMO opened at $232.88 on Tuesday. The company has a quick ratio of 1.27, a current ratio of 1.84 and a debt-to-equity ratio of 0.66. The stock has a market cap of $97.05 billion, a PE ratio of 24.54, a P/E/G ratio of 1.75 and a beta of 1.08. Thermo Fisher Scientific Inc. has a 52-week low of $181.51 and a 52-week high of $249.95.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, October 24th. The medical research company reported $2.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.07. The company had revenue of $5.92 billion during the quarter, compared to analysts’ expectations of $5.70 billion. Thermo Fisher Scientific had a net margin of 10.75% and a return on equity of 16.49%. Thermo Fisher Scientific’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same quarter last year, the company posted $2.31 EPS. As a group, equities research analysts expect that Thermo Fisher Scientific Inc. will post 11.04 earnings per share for the current year.

Thermo Fisher Scientific announced that its board has initiated a share repurchase program on Friday, September 7th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the medical research company to reacquire up to 2.1% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Monday, December 17th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Friday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 7.17%.

A number of research analysts have recently commented on TMO shares. Barclays lifted their price objective on shares of Thermo Fisher Scientific from $250.00 to $275.00 and gave the company an “overweight” rating in a research report on Monday, September 24th. Goldman Sachs Group downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research report on Monday, September 17th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $274.00 price objective for the company in a research report on Monday, October 1st. UBS Group began coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, October 9th. They issued a “buy” rating and a $295.00 price objective for the company. Finally, JPMorgan Chase & Co. restated an “overweight” rating and set a $300.00 target price on shares of Thermo Fisher Scientific in a research note on Thursday, July 26th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $263.55.

TRADEMARK VIOLATION WARNING: “Grand Jean Capital Management Inc. Sells 4,608 Shares of Thermo Fisher Scientific Inc. (TMO)” was reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2018/11/20/grand-jean-capital-management-inc-sells-4608-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Recommended Story: What Factors Can Affect Return on Equity?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.